MOREPEN LABORATORIES LTD.
BSE: 500288
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 541.04+16.9% | 462.81+1.1% | 457.57+23.8% | 369.53-5.6% | 391.28+2.4% | 381.94-5.3% | 403.25+5.1% | 383.70 |
| Other Income | 5.31-39.8% | 8.82+124.2% | 3.93-15.5% | 4.65+13.7% | 4.09+30.2% | 3.14-35.5% | 4.87+5.2% | 4.63 |
| Total Income | 546.35+15.8% | 471.63+2.2% | 461.50+23.3% | 374.18-5.4% | 395.38+2.7% | 385.08-5.6% | 408.13+5.1% | 388.33 |
| EXPENSES | ||||||||
| Expenditure | 474.20+6.8% | 444.00+3.2% | 430.08+20.7% | 356.41-7.2% | 384.02+4.4% | 367.78-2.6% | 377.75+9.3% | 345.48 |
| Tax | 18.15+142.0% | 7.50-5.3% | 7.93+76.6% | 4.49+36.3% | 3.29-39.0% | 5.39-29.9% | 7.69-29.6% | 10.93 |
| PROFIT | ||||||||
| PBT | 72.15+161.2% | 27.63-12.1% | 31.42+66.6% | 18.86+66.2% | 11.35-34.4% | 17.30-43.0% | 30.38-29.1% | 42.86 |
| Net Profit | 54.00+168.3% | 20.12-14.4% | 23.50+63.4% | 14.38+78.4% | 8.06-32.3% | 11.91-47.5% | 22.69-28.9% | 31.93 |
| KEY METRICS | ||||||||
| OPM % | 14.71%+9.67pp | 5.04%-4.11pp | 9.15%+1.30pp | 7.85%+3.01pp | 4.84%-3.06pp | 7.90%+3.08pp | 4.82%-3.88pp | 8.70% |
| NPM % | 9.88%+5.61pp | 4.27%-0.82pp | 5.09%+1.25pp | 3.84%+1.80pp | 2.04%-1.05pp | 3.09%-2.47pp | 5.56%-2.66pp | 8.22% |
| EPS | 0.99+167.6% | 0.37-14.0% | 0.43+65.4% | 0.26+73.3% | 0.15-25.0% | 0.20-51.2% | 0.41-31.7% | 0.60 |
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Annual General Meeting is scheduled to be held on Saturd…
BSE Filing ↗Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the elevation…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the a…
BSE Filing ↗Board Meeting
consider and approve unaudited standalone financial results,…
BSE Filing ↗Board Meeting
Consideration And Approval Of Quarterly Results (Q-1 FY 25) …
BSE Filing ↗Board Meeting
Consider and approve standalone and consolidated audited fin…
BSE Filing ↗Board Meeting
Consider and approve standalone and consolidated unaudited f…
BSE Filing ↗Board Meeting
consider and approve the standalone and consolidated un-audi…
BSE Filing ↗